| Title: |
Episode Payments for Transcatheter and Surgical Aortic Valve Replacement |
| Authors: |
Modi, Parth K.; Sukul, Devraj; Oerline, Mary; Thompson, Michael P.; Nallamothu, Brahmajee K.; Ellimoottil, Chad; Shahinian, Vahakn B.; Hollenbeck, Brent K. |
| Source: |
Circulation: Cardiovascular Quality and Outcomes ; volume 12, issue 12 ; ISSN 1941-7713 1941-7705 |
| Publisher Information: |
Ovid Technologies (Wolters Kluwer Health) |
| Publication Year: |
2019 |
| Description: |
Background: Aortic stenosis is the most common valvular heart disease in the United States. Transcatheter aortic valve replacement (TAVR) is increasingly being adopted as an alternative to surgical aortic valve replacement (SAVR). In an era of value-based payment reform, our objective was to better understand the economic impact of the use of TAVR and SAVR in the United States. Methods and Results: We performed a retrospective cohort study of Medicare beneficiaries who underwent TAVR or SAVR between 2012 and 2015. Using claims from a 20% sample of national fee-for-service Medicare beneficiaries, we calculated episode payments for patients who underwent aortic valve replacement from 90 days before aortic valve replacement through 90 days after hospital discharge. Among 18 804 eligible patients, 6455 underwent TAVR (34.3%), and 12 349 underwent SAVR (65.7%). After adjustment for patient characteristics, episode payments for TAVR were ≈7% lower than for SAVR (TAVR, $55 545 [95% CI, $54 643–56 446] versus $59 467 [95% CI, $58 723–60 211]; P |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1161/circoutcomes.119.005781 |
| DOI: |
10.1161/CIRCOUTCOMES.119.005781 |
| Availability: |
https://doi.org/10.1161/circoutcomes.119.005781; https://www.ahajournals.org/doi/full/10.1161/CIRCOUTCOMES.119.005781 |
| Accession Number: |
edsbas.A47F8632 |
| Database: |
BASE |